EDMOND, OKLAHOMA – From May 3 to May 6 Qualgen will attend the 2019 American Urological Association (AUA) annual meeting at the McCormick Place in Chicago, Illinois.
The American Urological Association continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the Annual Meeting—and other year-round educational offerings—the AUA sets the highest standards for urologic education, according to the AUA website.
“This will be our first AUA conference,” Nikki Good, Qualgen’s director of sales, said. “We are very excited to learn more about the association and meet many new people while we are there.”
The Annual Meeting, in its 114th year, is the largest gathering of urologists in the world, providing unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine.
Last year's meeting welcomed more than 16,000 attendees from more than 100 countries around the world, according to the AUA website.
“We are looking forward to showcasing our hormone pellets and teaching providers how beneficial they can be in their practice,” Good said.
Qualgen’s hormone pellets are one of the latest trending products in the anti-aging and urological industry. Hormone pellets can help with many conditions, but low testosterone is the most popular concern in the urologic industry.
Make sure to stop by and visit Qualgen at booth 3741 to learn how Qualgen’s pellets can benefit you and your practice. For more information about Qualgen visit www.qualgen.us and for more information about the AUA annual meeting visit www.aua2019.org.
ABOUT QUALGEN: Qualgen, a U.S. based company located in Edmond, Oklahoma, is a global leader in compounding pharmaceutical production. Founded in 2012, Qualgen offers bio-identical hormone replacement pellets, as well as, numerous scientifically advanced compounds in multiple markets around the world.